ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Mortality and Graft Loss Attributable to Readmission Following Kidney Transplantation.

    E. King, M. Bowring, L. Kucirka, M. McAdams-DeMarco, A. Massie, D. Segev.

    Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.

    BACKGROUND: Early hospital readmission (EHR) following kidney transplantation (KT) is independently associated with graft loss and mortality. Prior work assumes that this association is constant…
  • 2016 American Transplant Congress

    Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in De Novo Living Donor Kidney Transplant Recipients.

    A. Skaro,1 A. LeFever,2 J. Mathew,1 L. Gallon,1 J. Hie,1 C. Hansen,2 D. Stare,1 G. Johnson,3 J. Leventhal.1

    1Northwestern University, Chicago; 2NMH, Chicago; 3TRACT Therapeutics, Chicago.

    Therapeutic cell transfer using regulatory T cells (Tregs) holds the promise of reducing the need for drug based immunosuppression (IS) and improving long term graft…
  • 2016 American Transplant Congress

    Infectious Complication in Extremely Elderly Kidney Transplant (KT) Recipients: A Leading Cause of Death.

    J. Cabrera,1,3 M. Fernández-Ruiz,2 M. Molina,1 E. González,1 N. Polanco,1 F. López-Medrano,2 J. Aguado,2 M. Praga,1 A. Andrés.1

    1Department of Nephrology, Hospital Universitario “12 de Octubre”, Madrid, Spain; 2Unit of Infectious Diseases, Hospital Universitario “12 de Octubre”, Madrid, Spain; 3Department of Nephrology, Hospital Evangelico, Montevideo, Uruguay.

    Introduction: The incidence of infection after KT have been reported to directly increase with recipient's age, likely due to the combined effect of co-morbidities and…
  • 2016 American Transplant Congress

    SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes.

    A. Dotta,1 F. Caro,2 K. Peña Ponce,1 N. Ambrosi,2 J. Salaberry,2 X. García,1 E. Minué,1 L. León,1 F. Sánchez,2 F. Togniolo,1 C. Incardona,3 E. Chuluyan,2 D. Casadei.1

    1Instituto de Nefrología, Caba, Argentina; 2CEFYBO-UBA, Caba, Argentina; 3Fundación GADOR, Caba, Argentina.

    A lot of efforts have been done to identify the risk factors that tend to diminish the incidence of delayed graft function (DGF). Recently, the…
  • 2016 American Transplant Congress

    Enhanced Activation of Hemostasis During Kidney Transplantation in Patients on Dialysis Compared to Pre-Emptively Transplanted Patients.

    T. van den berg, G. Nieuwenhuijs-Moeke, S. Bakker, R. Pol, T. Lisman.

    Groningen Transplant Center, University Medical Center Groningen, Groningen, Netherlands.

    Introduction: It is generally assumed that dialysis patients (DP) have a more severe bleeding diathesis related to platelet dysfunction than pre-emptively transplanted patients (PEP) who…
  • 2016 American Transplant Congress

    Distinct Phenotype and Function of Plasmacytoid Dendritic Cells from Kidney Allografts in Tolerant Recipients.

    N. Oh,1,2 C. Yang,1,2,3 M. Tonsho,1,2 D. Ndishabandi,1,2,3 P. Russell,1,2 R. Colvin,1,3 J. Madsen,1,2 A. Alessandrini.1,2

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA; 2Department of Surgery, Massachusetts General Hospital, Boston, MA; 3Department of Pathology, Massachusetts General Hospital, Boston, MA.

    BACKGROUND: Cellular infiltrates in kidney allografts may be relevant to the induction or maintenance of regulatory tolerance. Here we examined the phenotype, anatomical distribution and…
  • 2016 American Transplant Congress

    Optimal Donor/Recipient Pairing for High KDPI Grafts Can Yield Similar Survival to Medium KDPI Grafts.

    M. Selim, E. Saad, M. Zimmerman, C. Johnson.

    Medical College of Wisconsin, Milwaukee.

    KDPI is a predictor of deceased-donor (DD) graft survival, calculated using donor factors. It does not consider recipient or other post-procurement factors. This retrospective analysis…
  • 2016 American Transplant Congress

    Improved Health Related Quality of Life Also in Older Recipients Following Kidney Transplantation.

    K. Lønning,1 K. Heldal,2,3 T. Bernklev,2,3 M. Andersen,1,4 A. Hartmann,1,3 N. Von der Lippe,3 A. Reisæter,1 K. Midtvedt.1

    1Department of Organ Transplantation, Oslo University Hospital, Oslo, Norway; 2Clinic of Internal Medicine, Telemark Hospital, Skien, Norway; 3Institute of Clinical Medicine, University of Oslo, Oslo, Norway; 4Department of Health Sciences, University of Oslo, Oslo, Norway.

    Background: There is a lack of knowledge regarding elderly patients with end stage renal disease (ESRD) and health related quality of life (HRQOL) after KTX.…
  • 2016 American Transplant Congress

    Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR® Gel.

    P. Vaitla, D. Daswatta, A. Guasch.

    Transplant, Emory University, Atlanta, GA.

    Recurrence of FSGS post kidney transplantation: Salvage therapy with ACTHAR® gel.Introduction:Recurrence of FSGS post kidney transplantation may reach 25-50%. Failure of treatment or incomplete remission…
  • 2016 American Transplant Congress

    Composite Score to Define the Risk of Allograft Loss After Standard-of-Care Treatment of Antibody-Mediated Rejection in Kidney Transplantation.

    D. Viglietti,1 A. Loupy,2 J. Duong Van Huyen,2 J. Verine,1 A. Zeevi,3 C. Legendre,2 D. Glotz,1 C. Lefaucheur.1

    1Saint-Louis Hospital, Paris, France; 2Necker Hospital, Paris, France; 3University of Pittsburgh Medical Center, Pittsburgh.

    The development of a reliable surrogate endpoint for allograft survival after AMR treatment is a current unmet need in clinical transplantation (FDA AMR Workshop). We…
  • « Previous Page
  • 1
  • …
  • 427
  • 428
  • 429
  • 430
  • 431
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences